Cost-Effectiveness of Policies Aimed at Increasing Organ Donation: The Case of Chile

Domı́nguez, J.; Harrison, Rodrigo; Atal, R.; Larraín, Luis

doi:10.1016/j.transproceed.2013.08.077

Cited by 4 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Motivos para essa diferença podem estar relacionados a oferta de leitos hospitalares, leitos de terapia intensiva, especialidade médicas e eventualmente até acordos de transferência inter-regionais de pacientes com enfermidades do sistema nervoso central 15,18 . Porém, novamente, tal estrutura a priori e teoricamente deveria ser oferecida por cada Regional de Saúde.…”

Section: Regional Deunclassified

Doadores de órgãos efetivos no Paraná e correlação com o Índice de Desenvolvimento Humano Municipal

Badoch¹,

Silveira²,

Silveira³

et al. 2021

R. Saúde Públ. Paraná

View full text Add to dashboard Cite

O Paraná se destaca na oferta de órgãos para transplante. O sistema é inserido no Sistema Único de Saúde, portanto influenciado por desigualdades regionais. O índice de desenvolvimento humano municipal (IDHM) é utilizado para análise e compreensão do desenvolvimento e sua relação com a doação de órgãos é desconhecida. Objetivo é analisar a correlação do IDHM com a doação de órgãos no estado no período de 2011 a 2019. Ocorreram 2875 doações efetivas em 7,27% dos municípios, com diferença do IDHM daqueles com (0,7514±0,03) e sem (0,6981±0,03) doação. Municípios com IDHM alto e muito alto (59,65% do total), foram responsáveis por 97,46% das doações. O agrupamento por Regionais de Saúde demonstra correlação linear positiva entre o IDHM e as doações efetivas por milhão de população, porém sem diferença do IDHM médio entre elas. Há correlação entre o IDHM e os doadores efetivos, não sendo o único fator de influência.

show abstract

Section: Regional Deunclassified

Doadores de órgãos efetivos no Paraná e correlação com o Índice de Desenvolvimento Humano Municipal

Badoch¹,

Silveira²,

Silveira³

et al. 2021

R. Saúde Públ. Paraná

View full text Add to dashboard Cite

show abstract

“…13 A recent systematic review identified economic evaluations surrounding kidney donation and allocation policies. 24 Many such policies have been found to be cost-effective, including developing donation protocols and teams with clearly defined responsibilities within hospitals, [25][26][27] accepting donation after circulatory death (DCD) donors, 28,29 accepting expanded criteria donors, 30 adopting an opt-out model of consent, 31 and accepting donors with potential hepatitis C infection. [32][33][34] In this study, we sought to determine the cost-effectiveness of increasing utilization of kidneys from potential deceased donors with PBM in the Australian setting and to explore how individual patients would be impacted.…”

mentioning

confidence: 99%

Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting

Hedley

Kelly

Wyld

et al. 2023

Transplantation Direct

View full text Add to dashboard Cite

Background. Kidneys from potential deceased donors with brain cancer are often foregone due to concerns of cancer transmission risk to recipients. There may be uncertainty around donors’ medical history and their absolute transmission risk or risk-averse decision-making among clinicians. However, brain cancer transmissions are rare, and prolonging waiting time for recipients is harmful. Methods. We assessed the cost-effectiveness of increasing utilization of potential deceased donors with brain cancer using a Markov model simulation of 1500 patients waitlisted for a kidney transplant, based on linked transplant registry data and with a payer perspective (Australian government). We estimated costs and quality-adjusted life-years (QALYs) for three interventions: decision support for clinicians in assessing donor risk, improved cancer classification accuracy with real-time data-linkage to hospital records and cancer registries, and increased risk tolerance to allow intermediate-risk donors (up to 6.4% potential transmission risk). Results. Compared with current practice, decision support provided 0.3% more donors with an average transmission risk of 2%. Real-time data-linkage provided 0.6% more donors (1.1% average transmission risk) and increasing risk tolerance (accepting intermediate-risk 6.4%) provided 2.1% more donors (4.9% average transmission risk). Interventions were dominant (improved QALYs and saved costs) in 78%, 80%, and 87% of simulations, respectively. The largest benefit was from increasing risk tolerance (mean +18.6 QALYs and AU$2.2 million [US$1.6 million] cost-savings). Conclusions. Despite the additional risk of cancer transmission, accepting intermediate-risk donors with brain cancer is likely to increase the number of donor kidneys available for transplant, improve patient outcomes, and reduce overall healthcare expenditure.

show abstract

Hypertension in the Kidney Transplant Recipient

Varas

Vella

2016

Core Concepts in Hypertension in Kidney Disease

View full text Add to dashboard Cite

Cost-Effectiveness of Policies Aimed at Increasing Organ Donation: The Case of Chile

Abstract: Our estimates suggest that these policies have a large cost-saving potential. In fact, considering implementation costs, cost reduction is positive after 4 additional donors pmp, and increasing afterward.

Cited by 4 publications

References 9 publications

Doadores de órgãos efetivos no Paraná e correlação com o Índice de Desenvolvimento Humano Municipal

Doadores de órgãos efetivos no Paraná e correlação com o Índice de Desenvolvimento Humano Municipal

Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting

Hypertension in the Kidney Transplant Recipient

Contact Info

Product

Resources

About